Attention Deficit/Hyperactivity Disorder among Adults in the United States: Trend in Diagnosis and Use of Pharmacotherapy

Author： >   Robison Linda M.   Castillo Leigh V.   Bowen Kurt A.   Schmidt Jennifer M.   Oganov Ambartsum M.  

Publisher： Adis International

ISSN： 1178-2595

Source： Pharmaceutical Medicine, Vol.26, Iss.2, 2012-04, pp. : 97-101

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacotherapy of Attention Deficit Hyperactivity Disorder in Adults

By Wilens T.E.   Biederman J.   Spencer T.J.  

CNS Drugs, Vol. 9, Iss. 5, 1998-05 ,pp. : 347-356

Adis International

Access to resources Recommend Favorite

Comorbid Attention Deficit/Hyperactivity Disorder and Substance Use Disorder: Treatment Considerations

By  

Current Drug Abuse Reviews, Vol. 5, Iss. 3, 2012-09 ,pp. : 190-198

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacotherapy of Attention-Deficit Hyperactivity Disorder in Adolescents

By Childress Ann C.  

Drugs, Vol. 72, Iss. 3, 2012-02 ,pp. : 309-325

Adis International

Access to resources Recommend Favorite

Atomoxetine: A Review of its Use in Adults with Attention Deficit Hyperactivity Disorder

By Simpson D.   Plosker G.L.  

Drugs, Vol. 64, Iss. 2, 2004-01 ,pp. : 205-222

Adis International

Access to resources Recommend Favorite

There is strong support for the use of methylphenidate to treat adults with attention-deficit hyperactivity disorder

By  

Inpharma, Vol. 1, Iss. 1427, 2004-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite